Strs Ohio Purchases New Holdings in Addus HomeCare Corporation $ADUS

Key Points

• Strs Ohio has made a new investment in Addus HomeCare Corporation by purchasing 6,600 shares valued at approximately $653,000 in the first quarter.
• Institutional investors currently own 95.35% of Addus HomeCare's stock, with significant purchases also made by firms like Nuveen LLC and Allianz Asset Management GmbH.
• Addus HomeCare reported an EPS of $1.49 for the quarter, exceeding expectations, and analysts maintain a consensus rating of "Buy" with a target price averaging $138.89.

Strs Ohio purchased a new stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 6,600 shares of the company's stock, valued at approximately $653,000.

Other institutional investors have also bought and sold shares of the company. BI Asset Management Fondsmaeglerselskab A S bought a new position in Addus HomeCare in the 1st quarter valued at $41,000. Caitong International Asset Management Co. Ltd boosted its position in shares of Addus HomeCare by 368.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company's stock worth $124,000 after buying an additional 987 shares during the period. Bailard Inc. bought a new stake in Addus HomeCare during the first quarter worth about $208,000. Heritage Family Offices LLP raised its stake in Addus HomeCare by 6.3% in the first quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock valued at $239,000 after buying an additional 143 shares during the period. Finally, Private Advisor Group LLC grew its position in shares of Addus HomeCare by 52.4% in the first quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock valued at $252,000 after purchasing an additional 875 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on ADUS shares. Macquarie reissued an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a report on Tuesday, June 10th. Royal Bank Of Canada lifted their price objective on Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a research report on Friday, August 22nd. Wall Street Zen raised Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday, June 29th. JMP Securities reissued a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Wednesday, July 16th. Finally, UBS Group assumed coverage on Addus HomeCare in a research note on Tuesday, September 2nd. They issued a "buy" rating and a $145.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Addus HomeCare presently has a consensus rating of "Buy" and an average price target of $138.89.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the completion of the transaction, the chief executive officer owned 166,461 shares of the company's stock, valued at approximately $19,134,691.95. This trade represents a 13.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Veronica Hill-Milbourne sold 1,571 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total transaction of $180,555.03. Following the sale, the director directly owned 5,067 shares of the company's stock, valued at $582,350.31. This trade represents a 23.67% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 34,310 shares of company stock valued at $3,958,375. Corporate insiders own 4.50% of the company's stock.

Addus HomeCare Trading Down 0.5%

Shares of Addus HomeCare stock traded down $0.57 during trading on Tuesday, reaching $113.63. 52,728 shares of the stock were exchanged, compared to its average volume of 185,495. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. The stock's fifty day moving average is $111.77 and its 200 day moving average is $107.90. The firm has a market cap of $2.09 billion, a price-to-earnings ratio of 25.00, a price-to-earnings-growth ratio of 1.70 and a beta of 0.85. Addus HomeCare Corporation has a 1 year low of $88.96 and a 1 year high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, topping analysts' consensus estimates of $1.45 by $0.04. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The company had revenue of $349.44 million during the quarter, compared to analyst estimates of $345.71 million. During the same period in the prior year, the business posted $1.35 earnings per share. Addus HomeCare's revenue for the quarter was up 21.8% on a year-over-year basis. As a group, equities research analysts expect that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.